1.
Kumar N, Kiuchi M, Tallarico JA, Schreiber SL. Small-molecule diversity using a skeletal transformation strategy. Org Lett. 2005;7(13):2535-8. doi:10.1021/ol0504345.
1.
Micalizio GC, Schreiber SL. An alkynylboronic ester annulation: development of synthetic methods for application to diversity-oriented organic synthesis. Angew Chem Int Ed Engl. 2002;41(17):3272-6. doi:10.1002/1521-3773(20020902)41:17<3272::AID-ANIE3272>3.0.CO;2-C.
1.
Crews CM, Collins JL, Lane WS, Snapper ML, Schreiber SL. GTP-dependent binding of the antiproliferative agent didemnin to elongation factor 1 alpha. J Biol Chem. 1994;269(22):15411-4.
1.
MacFerrin KD, Chen L, Terranova MP, Schreiber SL, Verdine GL. Overproduction of proteins using expression-cassette polymerase chain reaction. Methods Enzymol. 1993;217:79-102.
1.
Williams DR, Nag PP, Zorn N. Strategies for the synthesis of the novel antitumor agent peloruside A. Curr Opin Drug Discov Devel. 2008;11(2):251-71.
1.
McGuire L. Genome editing: Broad Institute keeps CRISPR tools open. Nature. 2016;534(7605):37. doi:10.1038/534037a.
1.
Scully SS, Tang AJ, Lundh M, Mosher CM, Perkins KM, Wagner BK. Small-molecule inhibitors of cytokine-mediated STAT1 signal transduction in β-cells with improved aqueous solubility. J Med Chem. 2013;56(10):4125-9. doi:10.1021/jm400397x.
1.
Wang X, Imber BS, Schreiber SL. Small-molecule reagents for cellular pull-down experiments. Bioconjug Chem. 2008;19(3):585-7. doi:10.1021/bc700297j.